Wednesday, February 04, 2026 | 02:42 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Natco Pharma Ltd / Announcements / BSE

Natco Pharma Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

01:17 PM, 3rd Feb 2026

NATCO receives Tentative Approval for Erdafitinib Tablets (generic of Balversa)

More Natco Pharma Ltd Announcements

    View more